跳至主要内容
临床试验/CTRI/2024/04/065353
CTRI/2024/04/065353尚未招募Unknown

Indian Childhood Acute Promyelocytic Leukemia Study - I-ChAMPs

Cankids, India [Srinivas Cankids APML Fund]0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • i. newly-diagnosed acute promyelocytic leukemia (APML) or medical records of patients with APML (for retrospective cohort)
  • ii. Age, 0-19 years
  • iii. signed written informed consent (waiver of consent for retrospective cohort)

排除标准

  • With respect to the primary purpose of the registry no exclusion criteria are specified.
  • Explicitly patients with unsuitability for intensive therapy, pre –induction deaths should
  • also be recorded in the registry including patients who refuse treatment, for any reason.

研究者

发起方
Cankids, India [Srinivas Cankids APML Fund]

相似试验